Clinical Trial Update: Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Tenofovir Disoproxil Fumarate for the treatment of Parkinson's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Parkinson Disease | Phase 1 | Status: RECRUITING